Published in Cancer Chemother Pharmacol on January 01, 1997
Imaging reversal of multidrug resistance in living mice with bioluminescence: MDR1 P-glycoprotein transports coelenterazine. Proc Natl Acad Sci U S A (2004) 1.56
Involvement of ABC transporters in melanogenesis and the development of multidrug resistance of melanoma. Pigment Cell Melanoma Res (2009) 1.38
New strategies to deliver anticancer drugs to brain tumors. Expert Opin Drug Deliv (2009) 1.29
Molecular pathways: regulation and therapeutic implications of multidrug resistance. Clin Cancer Res (2012) 1.20
Doxorubicin loaded pH-sensitive micelle targeting acidic extracellular pH of human ovarian A2780 tumor in mice. J Drug Target (2005) 1.16
The reversal effect of magnetic Fe3O4 nanoparticles loaded with cisplatin on SKOV3/DDP ovarian carcinoma cells. Int J Nanomedicine (2009) 1.08
In vivo evaluation of doxorubicin-loaded polymeric micelles targeting folate receptors and early endosomal pH in drug-resistant ovarian cancer. Mol Pharm (2009) 1.08
Effects of pluronic and doxorubicin on drug uptake, cellular metabolism, apoptosis and tumor inhibition in animal models of MDR cancers. J Control Release (2010) 1.03
Current approaches to enhance CNS delivery of drugs across the brain barriers. Int J Nanomedicine (2014) 1.02
Small-molecule multidrug resistance-associated protein 1 inhibitor reversan increases the therapeutic index of chemotherapy in mouse models of neuroblastoma. Cancer Res (2009) 1.01
Repositioning of Tyrosine Kinase Inhibitors as Antagonists of ATP-Binding Cassette Transporters in Anticancer Drug Resistance. Cancers (Basel) (2014) 0.95
Identification and characterization of the binding sites of P-glycoprotein for multidrug resistance-related drugs and modulators. Curr Med Chem Anticancer Agents (2004) 0.94
Dexrazoxane significantly impairs the induction of doxorubicin resistance in the human leukaemia line, K562. Br J Cancer (2001) 0.94
Trametinib modulates cancer multidrug resistance by targeting ABCB1 transporter. Oncotarget (2015) 0.94
Multilayer spheroids to quantify drug uptake and diffusion in 3D. Mol Pharm (2014) 0.91
MDR 1 activation is the predominant resistance mechanism selected by vinblastine in MES-SA cells. Br J Cancer (2000) 0.91
Induction of acquired drug resistance in endothelial cells and its involvement in anticancer therapy. J Hematol Oncol (2013) 0.91
A new model for studying tissue-specific mdr1a gene expression in vivo by live imaging. Proc Natl Acad Sci U S A (2009) 0.89
Which drug or drug delivery system can change clinical practice for brain tumor therapy? Neuro Oncol (2013) 0.88
Nanotechnology for CNS delivery of bio-therapeutic agents. Drug Deliv Transl Res (2013) 0.86
Influence of melanosome dynamics on melanoma drug sensitivity. J Natl Cancer Inst (2009) 0.86
Can nanomedicines kill cancer stem cells? Adv Drug Deliv Rev (2013) 0.86
Sensitization of ABCB1 overexpressing cells to chemotherapeutic agents by FG020326 via binding to ABCB1 and inhibiting its function. Biochem Pharmacol (2009) 0.85
Biomimetic Design of Protein Nanomaterials for Hydrophobic Molecular Transport. Adv Funct Mater (2012) 0.85
A promising strategy for overcoming MDR in tumor by magnetic iron oxide nanoparticles co-loaded with daunorubicin and 5-bromotetrandrin. Int J Nanomedicine (2011) 0.84
Discovery of novel antitumor antimitotic agents that also reverse tumor resistance. J Med Chem (2007) 0.84
Dose-dependent disposition of methotrexate in Abcc2 and Abcc3 gene knockout murine models. Drug Metab Dispos (2011) 0.82
Tunicamycin induces resistance to camptothecin and etoposide in human hepatocellular carcinoma cells: role of cell-cycle arrest and GRP78. Naunyn Schmiedebergs Arch Pharmacol (2009) 0.82
Bioimaging real-time PXR-dependent mdr1a gene regulation in mdr1a.fLUC reporter mice. J Pharmacol Exp Ther (2013) 0.82
In vitro and in vivo multidrug resistance reversal activity by a Betti-base derivative of tylosin. Br J Cancer (2010) 0.81
Extraction and RP-HPLC determination of taxol in rat plasma, cell culture and quality control samples. J Biomed Res (2013) 0.81
RNA binding protein RBM3 increases β-catenin signaling to increase stem cell characteristics in colorectal cancer cells. Mol Carcinog (2015) 0.80
Pharmacokinetics and pharmacodynamics of combination chemotherapy with paclitaxel and epirubicin in breast cancer patients. Br J Clin Pharmacol (2002) 0.80
ABCB1 (MDR1) induction defines a common resistance mechanism in paclitaxel- and olaparib-resistant ovarian cancer cells. Br J Cancer (2016) 0.80
Prognostic value of glucosylceramide synthase and P-glycoprotein expression in oral cavity cancer. Int J Clin Oncol (2016) 0.79
Cyclosporin A aerosol improves the anticancer effect of paclitaxel aerosol in mice. Trans Am Clin Climatol Assoc (2004) 0.78
Investigation of multidrug resistance in cultured human renal cell carcinoma cells by 31P-NMR spectroscopy and treatment survival assays. MAGMA (2005) 0.78
Scheduling of anticancer drugs: timing may be everything. Cell Cycle (2012) 0.78
Effect of cyclosporin on distribution of methotrexate into the brain of rats. J Vet Med Sci (2015) 0.77
Combined effect of papuamine and doxorubicin in human breast cancer MCF-7 cells. Oncol Lett (2014) 0.77
The strong in vivo anti-tumor effect of the UIC2 monoclonal antibody is the combined result of Pgp inhibition and antibody dependent cell-mediated cytotoxicity. PLoS One (2014) 0.75
Molecular Mimics of Classic P-Glycoprotein Inhibitors as Multidrug Resistance Suppressors and Their Synergistic Effect on Paclitaxel. PLoS One (2017) 0.75
Recurrent Male Breast Cancer Accompanied by Carcinomatous Pleuritis That Responded to Combination Therapy with High-Dose Toremifene and Docetaxel. Breast Care (Basel) (2010) 0.75
2-Amino-4-methyl-5-phenylethyl substituted-7-N-benzyl-pyrrolo[2,3-d]pyrimidines as novel antitumor antimitotic agents that also reverse tumor resistance. Bioorg Med Chem (2011) 0.75
Quinolizidinyl derivatives of iminodibenzyl and phenothiazine as multidrug resistance modulators in ovarian cancer cells. Invest New Drugs (2003) 0.75
Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature (2001) 11.72
The genome of the social amoeba Dictyostelium discoideum. Nature (2005) 9.18
Radical SAM, a novel protein superfamily linking unresolved steps in familiar biosynthetic pathways with radical mechanisms: functional characterization using new analysis and information visualization methods. Nucleic Acids Res (2001) 6.49
TFAR19, a novel apoptosis-related gene cloned from human leukemia cell line TF-1, could enhance apoptosis of some tumor cells induced by growth factor withdrawal. Biochem Biophys Res Commun (1999) 6.33
Isolation of INS-1-derived cell lines with robust ATP-sensitive K+ channel-dependent and -independent glucose-stimulated insulin secretion. Diabetes (2000) 6.27
Cytochrome c release and apoptosis induced by mitochondrial targeting of nuclear orphan receptor TR3. Science (2000) 4.57
BRCA2 is required for ionizing radiation-induced assembly of Rad51 complex in vivo. Cancer Res (1999) 4.16
Recruitment of CBP/p300 by the IFN beta enhanceosome is required for synergistic activation of transcription. Mol Cell (1998) 4.03
Pancreatic tumors show high levels of hypoxia. Int J Radiat Oncol Biol Phys (2000) 3.22
Acetylation of HMG I(Y) by CBP turns off IFN beta expression by disrupting the enhanceosome. Mol Cell (1998) 3.09
Direct antidiabetic effect of leptin through triglyceride depletion of tissues. Proc Natl Acad Sci U S A (1997) 3.07
Coordination of a transcriptional switch by HMGI(Y) acetylation. Science (2001) 2.69
BNIP3 heterodimerizes with Bcl-2/Bcl-X(L) and induces cell death independent of a Bcl-2 homology 3 (BH3) domain at both mitochondrial and nonmitochondrial sites. J Biol Chem (2000) 2.68
The urban homeless: estimating composition and size. Science (1987) 2.43
Approval summary: gemtuzumab ozogamicin in relapsed acute myeloid leukemia. Clin Cancer Res (2001) 2.35
Two FGF receptor genes are differentially expressed in epithelial and mesenchymal tissues during limb formation and organogenesis in the mouse. Development (1992) 2.34
Lithium-induced increase in human brain grey matter. Lancet (2000) 2.31
Raman scattering from high-frequency phonons in supported n-graphene layer films. Nano Lett (2006) 2.08
MR imaging differentiation of benign and malignant peripheral nerve sheath tumors: use of the target sign. Pediatr Radiol (1997) 2.02
Conversion of dorsal from an activator to a repressor by the global corepressor Groucho. Genes Dev (1997) 1.99
Thermal conductivity spectroscopy technique to measure phonon mean free paths. Phys Rev Lett (2011) 1.94
Local and propagated vascular responses evoked by focal synaptic activity in cerebellar cortex. J Neurophysiol (1997) 1.93
Linkage and association analysis of angiotensin I-converting enzyme (ACE)-gene polymorphisms with ACE concentration and blood pressure. Am J Hum Genet (2001) 1.91
Chemokine-dependent neutrophil recruitment in a murine model of Legionella pneumonia: potential role of neutrophils as immunoregulatory cells. Infect Immun (2001) 1.88
Protein folding is slaved to solvent motions. Proc Natl Acad Sci U S A (2006) 1.88
Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy. Proc Natl Acad Sci U S A (2001) 1.85
Effect of NASA light-emitting diode irradiation on wound healing. J Clin Laser Med Surg (2001) 1.85
Investigating neural primacy in Major Depressive Disorder: multivariate Granger causality analysis of resting-state fMRI time-series data. Mol Psychiatry (2010) 1.83
Quantitative analysis of the effect of the mutation frequency on the affinity maturation of single chain Fv antibodies. Proc Natl Acad Sci U S A (2000) 1.80
Lumbar hernia: clinical analysis of 11 cases. Hernia (2004) 1.79
Role of matrix metalloproteinases in renal pathophysiologies. Am J Physiol Renal Physiol (2006) 1.79
Phenotype of patients with peroxisomal disorders subdivided into sixteen complementation groups. J Pediatr (1995) 1.73
The mood stabilizer valproic acid activates mitogen-activated protein kinases and promotes neurite growth. J Biol Chem (2001) 1.73
Control of protein-ligand recognition using a stimuli-responsive polymer. Nature (1995) 1.73
Experimental investigation of heat conduction mechanisms in nanofluids. Clue on clustering. Nano Lett (2009) 1.71
Dorsal-mediated repression requires the formation of a multiprotein repression complex at the ventral silencer. Mol Cell Biol (1998) 1.71
Nonspecificity of assaying for IgG antibody to pneumolysin in circulating immune complexes as a means to diagnose pneumococcal pneumonia. Clin Infect Dis (2001) 1.70
Evidence of biologic epistasis between BDNF and SLC6A4 and implications for depression. Mol Psychiatry (2008) 1.66
Detection of microcystins, a blue-green algal hepatotoxin, in drinking water sampled in Haimen and Fusui, endemic areas of primary liver cancer in China, by highly sensitive immunoassay. Carcinogenesis (1996) 1.65
Bcl-2 and adenovirus E1B 19 kDA protein prevent E1A-induced processing of CPP32 and cleavage of poly(ADP-ribose) polymerase. Oncogene (1996) 1.64
Cardiotoxicity associated with the cancer therapeutic agent sunitinib malate. Ann Oncol (2008) 1.63
The role of HMG I(Y) in the assembly and function of the IFN-beta enhanceosome. EMBO J (1999) 1.62
Decreased mutation rate for cellular resistance to doxorubicin and suppression of mdr1 gene activation by the cyclosporin PSC 833. J Natl Cancer Inst (1995) 1.60
Use of voltage-sensitive dyes and optical recordings in the central nervous system. Prog Neurobiol (1995) 1.58
Complement inhibition enables renal allograft accommodation and long-term engraftment in presensitized nonhuman primates. Am J Transplant (2011) 1.57
Evans syndrome: results of a national survey. J Pediatr Hematol Oncol (1997) 1.56
Lithium increases N-acetyl-aspartate in the human brain: in vivo evidence in support of bcl-2's neurotrophic effects? Biol Psychiatry (2000) 1.55
Clinical and preclinical evidence for the neurotrophic effects of mood stabilizers: implications for the pathophysiology and treatment of manic-depressive illness. Biol Psychiatry (2000) 1.53
Radiation risk to low fluences of alpha particles may be greater than we thought. Proc Natl Acad Sci U S A (2001) 1.53
Crystal structure of the DNA binding domain of the replication initiation protein E1 from papillomavirus. Mol Cell (2000) 1.52
An interesting case of rifampicin-dependent/-enhanced multidrug-resistant tuberculosis. Int J Tuberc Lung Dis (2010) 1.52
Increased phonon scattering by nanograins and point defects in nanostructured silicon with a low concentration of germanium. Phys Rev Lett (2009) 1.50
Alteration of etoposide pharmacokinetics and pharmacodynamics by cyclosporine in a phase I trial to modulate multidrug resistance. J Clin Oncol (1992) 1.49
The bovine leukemia virus p34 is a transactivator protein. EMBO J (1987) 1.48
Uterine artery embolization for the treatment of uterine leiomyomata midterm results. J Vasc Interv Radiol (1999) 1.48
Lithium at 50: have the neuroprotective effects of this unique cation been overlooked? Biol Psychiatry (1999) 1.46
Modification of cisplatin toxicity with diethyldithiocarbamate. J Clin Oncol (1990) 1.46
Measurement of the W boson mass with the D0 detector. Phys Rev Lett (2012) 1.46
A complete set of maize individual chromosome additions to the oat genome. Plant Physiol (2001) 1.46
Interferon-kappa, a novel type I interferon expressed in human keratinocytes. J Biol Chem (2001) 1.45
Cooperation between bovine leukaemia virus transactivator protein and Ha-ras oncogene product in cellular transformation. EMBO J (1990) 1.44
Properties of regenerated mouse extensor digitorum longus muscle following notexin injury. Exp Physiol (2014) 1.44
On equilibria, stability, and instability of Hopfield neural networks. IEEE Trans Neural Netw (2000) 1.43
Targeted gene silencing of TLR4 using liposomal nanoparticles for preventing liver ischemia reperfusion injury. Am J Transplant (2011) 1.43
ADP is the cognate ligand for the orphan G protein-coupled receptor SP1999. J Biol Chem (2000) 1.42
Repair of calvarial nonunions by osteogenin, a bone-inductive protein. Plast Reconstr Surg (1990) 1.41
Production of correctly folded Fab antibody fragment in the cytoplasm of Escherichia coli trxB gor mutants via the coexpression of molecular chaperones. Protein Expr Purif (2001) 1.41
Role and therapeutic potential of PI3K-mTOR signaling in de novo resistance to BRAF inhibition. Pigment Cell Melanoma Res (2012) 1.41
Replication of genome-wide association studies (GWAS) loci for fasting plasma glucose in African-Americans. Diabetologia (2010) 1.41
Downregulation of the transforming growth factor-β/connective tissue growth factor 2 signalling pathway in venous malformations: its target potential for sclerotherapy. Br J Dermatol (2014) 1.41
Control of the mRNA for hepatic tryptophan oxygenase during hormonal and substrate induction. Proc Natl Acad Sci U S A (1975) 1.40
Comparison and validation of limited sampling equations for cyclosporine area-under-the-curve monitoring calculations in pediatric renal transplant recipients. Ther Drug Monit (1997) 1.39
NICE guidance does not tally with clinical practice--a district general experience. Rheumatology (Oxford) (2007) 1.39
Stability and Activities of Antibiotics Produced during Infection of the Insect Galleria mellonella by Two Isolates of Xenorhabdus nematophilus. Appl Environ Microbiol (1994) 1.39
Excitatory actions of GABA after neuronal trauma. J Neurosci (1996) 1.38
Neuroplasticity and cellular resilience in mood disorders. Mol Psychiatry (2000) 1.38
ATM-dependent phosphorylation of human Rad9 is required for ionizing radiation-induced checkpoint activation. J Biol Chem (2001) 1.38
Three-dimensional high-resolution quantitative microscopy of extended crystals. Nat Commun (2011) 1.37
Evidence for the involvement of the kainate receptor subunit GluR6 (GRIK2) in mediating behavioral displays related to behavioral symptoms of mania. Mol Psychiatry (2008) 1.36
Phase I and pharmacokinetic study of lexatumumab (HGS-ETR2) given every 2 weeks in patients with advanced solid tumors. Ann Oncol (2009) 1.33
beta-cell function in normal rats made chronically hyperleptinemic by adenovirus-leptin gene therapy. Diabetes (1997) 1.33
The phytophthora genome initiative database: informatics and analysis for distributed pathogenomic research. Nucleic Acids Res (2000) 1.32
Enhanced relaxation and intermixing in Ge islands grown on pit-patterned Si(001) substrates. Phys Rev Lett (2009) 1.31
Tissue triglycerides, insulin resistance, and insulin production: implications for hyperinsulinemia of obesity. Am J Physiol (1997) 1.31
Air pollution impairs cognition, provokes depressive-like behaviors and alters hippocampal cytokine expression and morphology. Mol Psychiatry (2011) 1.30
The neuronal repellent SLIT2 is a target for repression by EZH2 in prostate cancer. Oncogene (2010) 1.29
Accuracy of MR imaging for estimating intraosseous extent of osteosarcoma. AJR Am J Roentgenol (1996) 1.29
Coordination of PAD4 and HDAC2 in the regulation of p53-target gene expression. Oncogene (2010) 1.27
Detection and identification of microcystins in the drinking water of Haimen City, China. Nat Toxins (1996) 1.27
In vivo transfection of bovine leukemia provirus into sheep. Virology (1992) 1.25
Phase I trial of doxorubicin with cyclosporine as a modulator of multidrug resistance. J Clin Oncol (1994) 1.25
Limited heterogeneity of T cell receptor BV usage in aplastic anemia. J Clin Invest (2001) 1.25
High Ca(2+)-phosphate transfection efficiency enables single neuron gene analysis. Gene Ther (2004) 1.23
Resistance mechanisms in human sarcoma mutants derived by single-step exposure to paclitaxel (Taxol). Cancer Res (1996) 1.23
Cloning and functional characterization of mouse IkappaBepsilon. Proc Natl Acad Sci U S A (1997) 1.22
Distinct roles for spinophilin and neurabin in dopamine-mediated plasticity. Neuroscience (2006) 1.21
Ataxia-telangiectasia: phenotype/genotype studies of ATM protein expression, mutations, and radiosensitivity. Mol Genet Metab (2000) 1.21
Activation of an interleukin 1 converting enzyme-dependent apoptosis pathway by granzyme B. Proc Natl Acad Sci U S A (1996) 1.20